Kamada Ltd. (KMDA) Social Stream



Kamada Ltd. (KMDA): $5.22

0.10 (-1.88%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

Add KMDA to Watchlist
Sign Up

KAMADA LTD (KMDA) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering KMDA.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-08-12 1 $11 $10 $10.5 $6.03 74.13%
2021-11-23 2 $11 $10 $10.5 $6.03 74.13%
2022-11-23 1 $11 $11 $11 $6.03 82.42%
2023-11-14 1 $14 $11 $12.5 $6.03 107.3%
2023-11-15 1 $12 $11 $11.5 $6.03 90.71%
2023-12-07 1 $13 $11 $12 $6.03 99%

The Trend in the Analyst Price Target


Over the past 33 months, KMDA's average price target has gone up $1.

Over the past 42 weeks, KMDA's average upside potential has been 149.19%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-13 1 14 11 12.5 4.220 196.21%
2023-03-16 1 14 11 12.5 4.380 185.39%
2023-03-20 1 14 11 12.5 4.245 194.46%
2023-05-25 1 14 11 12.5 5.390 131.91%
2023-08-21 1 14 11 12.5 5.580 124.01%

KMDA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The Trend in the Broker Recommendations


KMDA's average broker recommendation rating improved by 0 over the prior 41 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for KMDA as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, KAMADA LTD's number of analysts covering the stock is higher than 2.83% of them.
  • In the context of Pharmaceutical Products stocks, KAMADA LTD's variance in analysts' estimates is lower than 64.6% of them.
  • In the context of Healthcare stocks, KAMADA LTD's average analyst price target is higher than 119.61% of them.
  • In terms of how KAMADA LTD fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 262.6% of that group.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to KAMADA LTD are SMMT, CARA, and OCUL.

What is the outlook for KMDA? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!